Skip to content
sellNotable cluster of 310b5-1 plan

John Oyler sold $86M of ONC

Chief Executive Officer at BeiGene, Ltd.. 240,810 shares at an average of $359.12, traded Aug 10, 2026, filed Aug 12, 2026.

Warning score
65
Value
$86M
240,810 shares
Holdings after
0
-100% from before
From 52-week low
+38%
low $260.27, close $359.00
From 52-week high
-5%
high $377.47, as of Aug 10, 2026

Score components

  • Role
    CEO
    +25
  • Trade size
    $86.5M at market
    +25
  • Share of holdings sold
    Sold 100% of holdings
    +20
  • Cluster
    3 insiders selling within 14 days
    +15
  • 10b5-1 plan
    Pre-scheduled under a 10b5-1 plan
    -20

What happened after comparable sells

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

Price around the trade, and since

From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.

ONCOct 9, 2026 · close 354.47
Since filing Aug 12, 2026: -1.3%SPY +1.0% · excess -2.3%

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™

Rows in this filing

Every transaction in Form 4 0001042047-26-000019, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Aug 10, 2026SOpen-market sale
American Depositary Shares10b5-1
-67$350.00$23k240,743Aug 12, 2026
Aug 10, 2026SOpen-market sale
American Depositary Shares10b5-1
-2,813$351.80$990k237,930Aug 12, 2026
Aug 10, 2026SOpen-market sale
American Depositary Shares10b5-1
-3,673$353.32$1.3M234,257Aug 12, 2026
Aug 10, 2026SOpen-market sale
American Depositary Shares10b5-1
-6,717$354.78$2.4M227,540Aug 12, 2026
Aug 10, 2026SOpen-market sale
American Depositary Shares10b5-1
-3,476$355.66$1.2M224,064Aug 12, 2026
Aug 10, 2026SOpen-market sale
American Depositary Shares10b5-1
-12,418$356.62$4.4M211,646Aug 12, 2026
Aug 10, 2026SOpen-market sale
American Depositary Shares10b5-1
-15,869$357.67$5.7M195,777Aug 12, 2026
Aug 10, 2026SOpen-market sale
American Depositary Shares10b5-1
-45,044$358.70$16M150,733Aug 12, 2026
Aug 10, 2026SOpen-market sale
American Depositary Shares10b5-1
-21,254$359.50$7.6M129,479Aug 12, 2026
Aug 10, 2026SOpen-market sale
American Depositary Shares10b5-1
-3,680$360.63$1.3M125,799Aug 12, 2026
Aug 11, 2026SOpen-market sale
American Depositary Shares10b5-1
-13,695$359.32$4.9M112,104Aug 12, 2026
Aug 11, 2026SOpen-market sale
American Depositary Shares10b5-1
-8,081$360.33$2.9M104,023Aug 12, 2026
Aug 11, 2026SOpen-market sale
American Depositary Shares10b5-1
-14,569$361.47$5.3M89,454Aug 12, 2026
Aug 11, 2026SOpen-market sale
American Depositary Shares10b5-1
-11,568$362.34$4.2M77,886Aug 12, 2026
Aug 11, 2026SOpen-market sale
American Depositary Shares10b5-1
-13,403$363.45$4.9M64,483Aug 12, 2026
Aug 11, 2026SOpen-market sale
American Depositary Shares10b5-1
-5,211$364.31$1.9M59,272Aug 12, 2026
Aug 11, 2026SOpen-market sale
American Depositary Shares10b5-1
-3,176$365.26$1.2M56,096Aug 12, 2026
Aug 11, 2026SOpen-market sale
American Depositary Shares10b5-1
-1,200$366.31$440k54,896Aug 12, 2026
Aug 11, 2026SOpen-market sale
American Depositary Shares10b5-1
-4$367.00$1,46854,892Aug 12, 2026
Aug 12, 2026SOpen-market sale
American Depositary Shares10b5-1
-1,980$354.71$702k52,912Aug 12, 2026
Aug 12, 2026SOpen-market sale
American Depositary Shares10b5-1
-2,515$356.43$896k50,397Aug 12, 2026
Aug 12, 2026SOpen-market sale
American Depositary Shares10b5-1
-15,396$357.63$5.5M35,001Aug 12, 2026
Aug 12, 2026SOpen-market sale
American Depositary Shares10b5-1
-20,899$358.41$7.5M14,102Aug 12, 2026
Aug 12, 2026SOpen-market sale
American Depositary Shares10b5-1
-14,102$359.12$5.1M0Aug 12, 2026

Related signals

Other insiders at BeiGene, Ltd. and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
39Weak
ONCsell 210b5-1
BeiGene, Ltd.
Chan Henry Lee
SVP, General Counsel
$418k
1,115 shares
-100%
33Weak
ONCsell 210b5-1
BeiGene, Ltd.
Xiaodong Wang
director, other
$11M
31,028 shares
-100%
40Moderate
ONCsell 310b5-1
BeiGene, Ltd.
Xiaodong Wang
director, other
$13M
38,287 shares
-527%
56Moderate
ONCsell 3
BeiGene, Ltd.
Titus B. Ball
Principal Accounting Officer
$47k
132 shares
-100%
45Moderate
ONCsell 410b5-1
BeiGene, Ltd.
Xiaobin Wu
President and COO
$106k
280 shares
-100%
39Weak
ONCsell 410b5-1
BeiGene, Ltd.
Chan Henry Lee
SVP, General Counsel
$960k
2,666 shares
-100%
72Notable
ONCsell 3
BeiGene, Ltd.
Aaron Rosenberg
Chief Financial Officer
$362k
1,157 shares
-100%
65Notable
ONCsell 3
BeiGene, Ltd.
Chan Henry Lee
SVP, General Counsel
$338k
1,044 shares
-100%
34Weak
ONCsell 310b5-1
BeiGene, Ltd.
Chan Henry Lee
SVP, General Counsel
$542k
1,669 shares
-100%
50Moderate
ONCsell 310b5-1
BeiGene, Ltd.
John Oyler
Chief Executive Officer
$35M
109,713 shares
-766%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

John Oyler sold $86M of ONC | InsiderTell